Michael Scherz

City:

Oberwil

Country:

Switzerland

Published Applications:

Last publication date:

2022-02-17

Top Assignees for applications by Michael Scherz

The entities that hold a legal rights for patent applications filed by inventor Scherz Michael:

Actelion Pharmaceuticals Ltd. 3 Allschwil, Switzerland
Metys Pharmaceuticals AG 2 Basel, Switzerland

Recent patent applications by Scherz Michael

Michael Scherz from Oberwil, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-02-17

US20220047587A1

Human necessities

SYNERGISTIC COMPOSITIONS COMPRISING R-2-(SUBSTITUTED-SULFONYL)-HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-6(2H)-ONES AND S-2-(SUBSTITUTED-SULFONYL)-HEXAHYDRO-PYRROLO[1,2-A]PYRAZIN-6(2H)-ONES IN A NON-RACEMIC RATIO

#2 | 2022-02-17

US20220047548A1

Human necessities

SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIO

#3 | 2021-12-30

US20210401811A1

Human necessities

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

#4 | 2020-10-22

US20200331919A1

Chemistry; metallurgy

Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio

#5 | 2018-12-06

US20180346472A1

Chemistry; metallurgy

Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio

#6 | 2015-09-24

US20150265580A1

Human necessities

Dosing regimen for a selective S1Preceptor agonist

#7 | 2014-10-23

US20140316140A1

Human necessities

Dosing regimen for a selective S1Pagonist

#8 | 2014-10-23

US20140315964A1

Human necessities

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

InventorID:

945916 ⎘